KERRY ANDERSON: Open Payments
NPI 1346763927 · HAMPSTEAD, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 20 payments from 8 companies in 2025. Trend: 2023 $226 · 2024 $551 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $249 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Novo Nordisk Inc | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| PFIZER INC. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: UBRELVY, QULIPTA, AIRSUPRA, VRAYLAR, Auvelity, Wegovy, CAPLYTA, SKYRIZI.
Industry payments across NH — which companies pay providers there.
